| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |